Clinical Trial

Feasibility Study for Repurposing RET Inhibitors

Name: Feasibility Study for Repurposing RET Inhibitors — clinical trial record (NCT07146893)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FEATHER

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the effects of selpercatinib on cachexia and anorexia in patients diagnosed with NSCLC, colorectal cancer, or pancreatic cancer.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-08-21; most recent amendment 2026-01-13.

Trial Details

NCT Number	NCT07146893
Lead Sponsor	University of Oklahoma Collaborators: Presbyterian Health Foundation
Conditions	Cachexia-Anorexia Syndrome
Enrollment	7 participants
Start Date	2026-02-26
Primary Completion	2027-02-23 (estimated)
Study Completion	2028-02-23 (estimated)
Updated on ClinicalTrials.gov	2026-01-15